Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

"Off-label" stent therapy 2-year comparison of drug-eluting versus bare-metal stents.

Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Baki TT, Little WC.

J Am Coll Cardiol. 2008 Feb 12;51(6):607-14. doi: 10.1016/j.jacc.2007.08.064.

2.

Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal stent coronary interventions.

Jensen LO, Maeng M, Kaltoft A, Thayssen P, Hansen HH, Bottcher M, Lassen JF, Krussel LR, Rasmussen K, Hansen KN, Pedersen L, Johnsen SP, Soerensen HT, Thuesen L.

J Am Coll Cardiol. 2007 Jul 31;50(5):463-70. Epub 2007 Jun 29. Review.

3.

[Drug-eluting stent-associated thrombosis: clinical relevance of impaired vessel-wall healing].

Koziński M, Sukiennik A, Sinkiewicz W, Kochman W, Kubica J.

Postepy Hig Med Dosw (Online). 2008 May 8;62:185-205. Review. Polish.

4.

Drug-eluting stents versus bare-metal stents in diabetic patients with ST-segment elevation acute myocardial infarction: a pooled analysis of individual patient data from seven randomized trials.

Iijima R, Byrne RA, Dibra A, Ndrepepa G, Spaulding C, Laarman GJ, Menichelli M, Valgimigli M, Di Lorenzo E, Kaiser C, Tierala I, Mehilli J, Suttorp MJ, Violini R, Schömig A, Kastrati A.

Rev Esp Cardiol. 2009 Apr;62(4):354-64. Review. English, Spanish.

5.

Off-label use of stents: bare-metal versus drug-eluting stents.

Girod JP, Mulukutla SR, Marroquin OC.

Expert Rev Cardiovasc Ther. 2008 Sep;6(8):1095-106. doi: 10.1586/14779072.6.8.1095. Review.

PMID:
18793112
6.
7.
8.

Is late stent thrombosis in drug-eluting stents a real clinical issue? A single-center experience and review of the literature.

Carlsson J, von Wagenheim B, Linder R, Anwari TM, Qvist J, Petersson I, Magounakis T, Lagerqvist B.

Clin Res Cardiol. 2007 Feb;96(2):86-93. Epub 2006 Dec 22. Review.

PMID:
17180577
9.

Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction.

Pasceri V, Patti G, Speciale G, Pristipino C, Richichi G, Di Sciascio G.

Am Heart J. 2007 May;153(5):749-54. Review.

PMID:
17452148
10.

Clinical outcomes of dialysis patients after implantation of DES: meta analysis and systematic review of literature.

Athappan G, Ponniah T.

Minerva Cardioangiol. 2009 Jun;57(3):291-7. Review.

PMID:
19513010
11.

Clinical impact of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized clinical trials.

Piscione F, Piccolo R, Cassese S, Galasso G, Chiariello M.

Catheter Cardiovasc Interv. 2009 Aug 1;74(2):323-32. doi: 10.1002/ccd.22017. Review.

PMID:
19360858
12.

A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease.

Schömig A, Dibra A, Windecker S, Mehilli J, Suárez de Lezo J, Kaiser C, Park SJ, Goy JJ, Lee JH, Di Lorenzo E, Wu J, Jüni P, Pfisterer ME, Meier B, Kastrati A.

J Am Coll Cardiol. 2007 Oct 2;50(14):1373-80. Epub 2007 Aug 21. Review.

13.

Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.

Palmerini T, Biondi-Zoccai G, Della Riva D, Mariani A, Sabaté M, Smits PC, Kaiser C, D'Ascenzo F, Frati G, Mancone M, Genereux P, Stone GW.

J Am Coll Cardiol. 2014 Feb 4;63(4):299-307. doi: 10.1016/j.jacc.2013.09.061. Epub 2013 Nov 6. Review.

14.

Use of drug-eluting stents in acute myocardial infarction: a systematic review and meta-analysis.

Brar SS, Leon MB, Stone GW, Mehran R, Moses JW, Brar SK, Dangas G.

J Am Coll Cardiol. 2009 May 5;53(18):1677-89. doi: 10.1016/j.jacc.2009.03.013. Review.

15.

Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction.

Kastrati A, Dibra A, Spaulding C, Laarman GJ, Menichelli M, Valgimigli M, Di Lorenzo E, Kaiser C, Tierala I, Mehilli J, Seyfarth M, Varenne O, Dirksen MT, Percoco G, Varricchio A, Pittl U, Syvänne M, Suttorp MJ, Violini R, Schömig A.

Eur Heart J. 2007 Nov;28(22):2706-13. Epub 2007 Sep 27. Review.

16.

The effect of drug-eluting stents on intermediate angiographic and clinical outcomes in diabetic patients: insights from randomized clinical trials.

Kumbhani DJ, Bavry AA, Kamdar AR, Helton TJ, Bhatt DL.

Am Heart J. 2008 Apr;155(4):640-7. doi: 10.1016/j.ahj.2007.11.017. Epub 2008 Feb 21. Review.

PMID:
18371470
17.

Stent choice in primary percutaneous coronary intervention: drug-eluting stents or bare metal stents?

Valgimigli M, Airoldi F, Zimarino M.

J Cardiovasc Med (Hagerstown). 2009 Oct;10 Suppl 1:S17-26. doi: 10.2459/01.JCM.0000362040.25767.f5. Review.

PMID:
19851216
18.

[Stent thrombosis in the era of drug-eluting stents].

Wöhrle J.

Herz. 2007 Aug;32(5):411-8. Review. German.

PMID:
17687531
19.

Drug-eluting stents and stent thrombosis: a cause for concern?

Wernick MH, Jeremias A, Carrozza JP.

Coron Artery Dis. 2006 Dec;17(8):661-5. Review.

PMID:
17119373
20.

Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials.

De Luca G, Dirksen MT, Spaulding C, Kelbaek H, Schalij M, Thuesen L, van der Hoeven B, Vink MA, Kaiser C, Musto C, Chechi T, Spaziani G, Díaz de la Llera LS, Pasceri V, Di Lorenzo E, Violini R, Cortese G, Suryapranata H, Stone GW; Drug-Eluting Stent in Primary Angioplasty (DESERT) Cooperation.

Arch Intern Med. 2012 Apr 23;172(8):611-21; discussion 621-2. doi: 10.1001/archinternmed.2012.758. Review.

PMID:
22529227
Items per page

Supplemental Content

Write to the Help Desk